Skip to main content
TipRanks
Go Ultimate75% OFF

Anatara Lifesciences Ltd (ANR) Share Price & Analysis

2 Followers

ANR Stock Chart & Stats

A$0.01A$0.00(0.00%)
At close: 9:59 AM GMT+11
AU$0.01AU$0.0105AU$0.011Jun 9Jun 22Jun 30Jul 22Jul 27Sep 1
Day’s Range
AUD 0.01 - AUD 0.01
52-Week Range
AUD 0.01 - AUD 0.02
Previous Close
AUD 0.01
Volume
N/A
Average Volume (3M)
59.97K
Market Cap
AUD 2.53M
Enterprise Value
AUD 2.69M
Total Cash (Recent Filing)
AUD 470.92K
Total Debt (Recent Filing)
AUD 0
Price to Earnings (P/E)
―
Beta
1.05
Next Earnings
Feb 24, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Debt-Free Balance Sheet

Zero debt reduces mandatory financing costs and near-term leverage risk, while positive equity provides a stronger capital base. This gives Anatara greater flexibility to fund development or pursue partnerships, although continued losses could reduce that cushion.

Narrower Net Losses

The reduction in net losses indicates some progress in controlling the earnings deficit, even though profitability has not been achieved. If sustained, this could improve capital efficiency and reduce the scale of future funding requirements.

Focused Gastrointestinal Product Strategy

A focused gastrointestinal-health strategy can concentrate limited research resources around a defined therapeutic and consumer need. Oral delivery may support product usability, while clinical evaluation and partnership preparation provide potential routes toward future commercialization.

Bears Say

Revenue Deterioration

The loss of reported revenue leaves no established top-line base to support ongoing operations or validate commercial traction. Rebuilding consistent sales will be essential before Anatara can demonstrate recurring demand, operating leverage, or meaningful scale.

Persistent Unprofitability

Persistent operating and net losses, combined with negative gross profit, show that current economics do not cover the cost of generating revenue. Without durable margin improvement, growth or commercialization could require substantial additional capital.

Dependence On External Funding

Negative operating and free cash flow indicate that the business cannot currently self-fund its activities. Continued dependence on external capital raises execution and dilution risk, particularly if commercialization takes longer or financing conditions become less supportive.

Anatara Lifesciences Ltd News

ANR FAQ

What was Anatara Lifesciences Ltd’s price range in the past 12 months?
Anatara Lifesciences Ltd lowest share price was AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is Anatara Lifesciences Ltd’s market cap?
Anatara Lifesciences Ltd’s market cap is AU$2.53M.
When is Anatara Lifesciences Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Anatara Lifesciences Ltd’s earnings last quarter?
Anatara Lifesciences Ltd released its earnings results on Oct 23, 2026. The company reported -AU$0.001 earnings per share for the quarter.
Is Anatara Lifesciences Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Anatara Lifesciences Ltd pay dividends?
Anatara Lifesciences Ltd does not currently pay dividends.
What is Anatara Lifesciences Ltd’s EPS estimate?
Anatara Lifesciences Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anatara Lifesciences Ltd have?
Anatara Lifesciences Ltd has 316,310,400 shares outstanding.
What happened to Anatara Lifesciences Ltd’s price movement after its last earnings report?
Anatara Lifesciences Ltd reported an EPS of -AU$0.001 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Anatara Lifesciences Ltd?
Currently, no hedge funds are holding shares in AU:ANR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology